GNL Gut and Liver
  1. Romelia Barba Bernal, Esli Medina-Morales, Daniela Goyes, Vilas Patwardhan, Alan Bonder. Management of Autoimmune Liver Diseases after Liver Transplantation. Transplantology 2021;2:162
    https://doi.org/10.3390/transplantology2020016
  2. Fiorella D’Onofrio, Giorgia Renga, Matteo Puccetti, Marilena Pariano, Marina Maria Bellet, Ilaria Santarelli, Claudia Stincardini, Paolo Mosci, Maurizio Ricci, Stefano Giovagnoli, Claudio Costantini, Luigina Romani. Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis. Cells 2021;10:1622
    https://doi.org/10.3390/cells10071622
  3. Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Colangitis esclerosante primaria y enfermedad inflamatoria intestinal: interrelación intestino-hígado. Gastroenterología y Hepatología 2019;42:316
    https://doi.org/10.1016/j.gastrohep.2019.02.004
  4. M Cauldwell, FL Mackie, PJ Steer, MA Henehghan, JH Baalman, J Brennand, T Johnston, S Dockree, C Hedley, S Jarvis, S Khan, FM McAuliffe, L Mackillop, L Penna, B Smith, P Trivedi, S Verma, R Westbrook, S Winifield, C Williamson. Pregnancy outcomes in women with primary biliary cholangitis and primary sclerosing cholangitis: a retrospective cohort study. BJOG 2020;127:876
    https://doi.org/10.1111/1471-0528.16119
  5. Meng-Tzu Weng, I-Lun Shih, Chien-Chih Tung, Yew-Loong Leong, Ming-Jium Shieh, Cheng-Yi Wang, Jau-Min Wong, Yen-Hsuan Ni, Shu-Chen Wei. Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease. Intest Res 2022;20:224
    https://doi.org/10.5217/ir.2021.00042
  6. Pilar López Serrano, Juan Turnes Vázquez. Autoimmune hepatitis, primary sclerosing cholangitis, and inflammatory bowel disease. Sequential overlap syndrome: a twist to the mosaic of autoimmunity. Rev Esp Enferm Dig 2020;112
    https://doi.org/10.17235/reed.2020.7512/2020
  7. Neil Bharat Marya, James H Tabibian. Role of endoscopy in the management of primary sclerosing cholangitis. WJGE 2019;11:84
    https://doi.org/10.4253/wjge.v11.i2.84
  8. Tina Boortalary, David Loren. Hepato-Pancreato-Biliary Malignancies. 2019.
    https://doi.org/10.1007/978-3-030-41683-6_15
  9. João Sabino, Joren tenHove, Joana Torres. Biomarkers in Inflammatory Bowel Diseases. 2019.
    https://doi.org/10.1007/978-3-030-11446-6_16
  10. Ishaan Vohra, Harishankar Gopakumar, Dushyant Singh Dahiya, Michel Kahaleh, Neil Sharma. Racial Disparities in Inpatient Hospital Outcomes of Primary Sclerosing Cholangitis in United States: Nationwide Analysis. Diagnostics 2024;14:2493
    https://doi.org/10.3390/diagnostics14222493
  11. Paulina Núñez F, Fabiola Castro, Gabriel Mezzano, Rodrigo Quera, Diego Diaz, Lorena Castro. Hepatobiliar manifestations in inflammatory bowel disease: A practical approach. WJH 2022;14:319
    https://doi.org/10.4254/wjh.v14.i2.319
  12. Hiroyuki Yoshida, Masahiro Shiokawa, Takeshi Kuwada, Yuya Muramoto, Sakiko Ota, Yoshihiro Nishikawa, Hirona Maeda, Nobuyuki Kakiuchi, Kanako Okamoto, Hajime Yamazaki, Masataka Yokode, Takeharu Nakamura, Shimpei Matsumoto, Tomonori Hirano, Hirokazu Okada, Saiko Marui, Yuko Sogabe, Tomoaki Matsumori, Atsushi Mima, Norimitsu Uza, Yuji Eso, Atsushi Takai, Ken Takahashi, Yoshihide Ueda, Yuzo Kodama, Tsutomu Chiba, Hiroshi Seno. Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis. J Gastroenterol 2023;58:778
    https://doi.org/10.1007/s00535-023-02006-6
  13. Neeraj Narula, Achuthan Aruljothy, Emily C. L. Wong, Ravi Homenauth, Abdul‐Aziz Alshahrani, John K. Marshall, Walter Reinisch. The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies. UEG Journal 2021;9:581
    https://doi.org/10.1002/ueg2.12094
  14. Naik Arbabzada, Liz Dennett, Guanmin Meng, Farhad Peerani. The Effectiveness of Oral Vancomycin on Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis: A Systematic Review. 2024
    https://doi.org/10.1093/ibd/izae257
  15. Vlad Alexandru Ionescu, Gina Gheorghe, Valentin Nicolae Varlas, Ana Maria Alexandra Stanescu, Camelia Cristina Diaconu. Hepatobiliary Impairments in Patients with Inflammatory Bowel Diseases: The Current Approach. Gastroenterology Insights 2022;14:13
    https://doi.org/10.3390/gastroent14010002
  16. Aalam Sohal, Sanya Kayani, Kris V. Kowdley. Primary Sclerosing Cholangitis. Clinics in Liver Disease 2024;28:129
    https://doi.org/10.1016/j.cld.2023.07.005
  17. Min Chen, Yanke Lin, Yongkang Dang, Yifei Xiao, Fugui Zhang, Guanghui Sun, Xuejun Jiang, Li Zhang, Jianhao Du, Shuyi Duan, Xiaojian Zhang, Zifei Qin, Jing Yang, Kaisheng Liu, Baojian Wu. Reprogramming of rhythmic liver metabolism by intestinal clock. Journal of Hepatology 2023;79:741
    https://doi.org/10.1016/j.jhep.2023.04.040
  18. Roberta Maria Nicolosi, Graziana Bonincontro, Elena Imperia, Camilla Badiali, Daniela De Vita, Fabio Sciubba, Laura Dugo, Michele Pier Luca Guarino, Annamaria Altomare, Giovanna Simonetti, Gabriella Pasqua. Protective Effect of Procyanidin-Rich Grape Seed Extract against Gram-Negative Virulence Factors. Antibiotics 2023;12:1615
    https://doi.org/10.3390/antibiotics12111615
  19. Sabina Wiecek. Hepatitis A and Other Associated Hepatobiliary Diseases. 2023.
    https://doi.org/10.5772/intechopen.90714
  20. Aiva Lundberg Båve, Annika Bergquist, Matteo Bottai, Anna Warnqvist, Erik von Seth, Caroline Nordenvall. Increased risk of cancer in patients with primary sclerosing cholangitis. Hepatol Int 2021;15:1174
    https://doi.org/10.1007/s12072-021-10214-6
  21. Laura Berkhout, Roja Barikbin, Birgit Schiller, Gevitha Ravichandran, Till Krech, Katrin Neumann, Gabriele Sass, Gisa Tiegs. Deletion of tumour necrosis factor α receptor 1 elicits an increased TH17 immune response in the chronically inflamed liver. Sci Rep 2019;9
    https://doi.org/10.1038/s41598-019-40324-z
  22. Johan Vessby, Maria Lampinen, Mikael Åberg, Fredrik Rorsman, Agneta Siegbahn, Alkwin Wanders, Marie Carlson. Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis. Upsala Journal of Medical Sciences 2019;124:238
    https://doi.org/10.1080/03009734.2019.1689209
  23. Rebekka J.S. Salzmann, Christina Krötz, Tudor Mocan, Lavinia P. Mocan, Cristiana Grapa, Sophia Rottmann, Ramona Reichelt, Cindy M. Keller, Bettina Langhans, Frederik Schünemann, Alexander Pohl, Thomas Böhler, Käthe Bersiner, Marcin Krawczyk, Piotr Milkiewicz, Zeno Sparchez, Frank Lammert, Sebastian Gehlert, Maria A. Gonzalez-Carmona, Arnulf Willms, Christian P. Strassburg, Miroslaw T. Kornek, Leona Dold, Veronika Lukacs-Kornek. Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis. 2024;8
    https://doi.org/10.1097/HC9.0000000000000380
  24. Sarah Pötter-Lang, Ahmed Ba-Ssalamah, Nina Bastati, Alina Messner, Antonia Kristic, Raphael Ambros, Alexander Herold, Jacqueline C. Hodge, Michael Trauner. Modern imaging of cholangitis. 2021;94
    https://doi.org/10.1259/bjr.20210417
  25. Richard Kellermayer. Should all pediatric patients with Type 1 Autoimmune Hepatitis be screened for inflammatory bowel disease?. JHEP Reports 2024:101291
    https://doi.org/10.1016/j.jhepr.2024.101291
  26. Arnold N Forlemu, Raissa Nana Sede Mbakop , Shehroz Aslam, Zaid Ansari, Indu Srinivasan, Keng-Yu Chuang. Effect of Comorbidities on Inflammatory Bowel Disease-Related Colorectal Cancer: A Nationwide Inpatient Review. 2022
    https://doi.org/10.7759/cureus.27599
  27. Yuanyuan Li, Haoyu Xue, Su Fang, Guofeng Wang, Yahang Wang, Tianming Wang, Rong Shi, Jiasheng Wu, Yueming Ma. Time-series metabolomics insights into the progressive characteristics of 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestatic liver fibrosis in mice. Journal of Pharmaceutical and Biomedical Analysis 2021;198:113986
    https://doi.org/10.1016/j.jpba.2021.113986
  28. Ida Schregel, Guilherme P. Ramos, Stephanie Ioannou, Emma Culver, Martti Färkkilä, Christoph Schramm, John Eaton, Cynthia Levy, Olivier Chazouilleres, Tobias Müller, Jeremy Nayagam, Deepak Joshi, Ehud Zigmond, Oren Shibolet, Joost P.H. Drenth, Frank Hoentjen, Anja Geerts, Tobias J. Weismüller, Taotao Zhou. Evaluation of Tofacitinib in Primary Sclerosing Cholangitis and Associated Colitis: A Multicenter, Retrospective Study. Clinical Gastroenterology and Hepatology 2023;21:3448
    https://doi.org/10.1016/j.cgh.2023.01.014
  29. Alejandro Mínguez Sabater, Isabel Conde Amiel, Pablo Ladrón Abia, Sara Martínez Delgado, Ángel Camarasa Pérez, Marina Berenguer. Características e impacto del sexo en una cohorte de pacientes con colangitis esclerosante primaria: experiencia de un centro trasplantador de la cuenca mediterránea. Gastroenterología y Hepatología 2022;45:177
    https://doi.org/10.1016/j.gastrohep.2021.03.017
  30. Yujie Zhang, Xinbao Gao, Zhiyi He, Hui Jia, Min Chen, Xuan Wang, Liu Hong, Yuanyuan Cui, Jian Wan. Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: A systematic review and meta‐analysis. Liver International 2022;42:1814
    https://doi.org/10.1111/liv.15339
  31. Sara Momtazmanesh, Mehran Gholami, Neda Pak, Ali Reza Sima, Seyed Ali Montazeri, Shadi Kolahdoozan, Homayoun Vahedi, Amir Reza Radmard. The clinical significance of biliary findings in magnetic resonance enterography of patients with inflammatory bowel disease. Pol J Radiol 2022;87:613
    https://doi.org/10.5114/pjr.2022.121443
  32. Beata Kasztelan-Szczerbinska, Anna Rycyk-Bojarzynska, Agnieszka Szczerbinska, Halina Cichoz-Lach. Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies—A Critical Overview. Nutrients 2023;15:760
    https://doi.org/10.3390/nu15030760
  33. Gary C. Kanel. Atlas of Liver Pathology. 2023.
    https://doi.org/10.1016/B978-0-323-82533-7.00004-1
  34. Mike Van Der Have, Bas Oldenburg. Is Ulcerative Colitis Associated With Primary Sclerosing Cholangitis an Undertreated Condition?. 2020;26:780
    https://doi.org/10.1093/ibd/izz211
  35. Henrique C. Rocha, Eduardo G. Vilela. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases. Gastroenterología y Hepatología 2022;45:83
    https://doi.org/10.1016/j.gastrohep.2021.03.011
  36. Alejandro Mínguez Sabater, Isabel Conde Amiel, Pablo Ladrón Abia, Sara Martínez Delgado, Ángel Camarasa Pérez, Marina Berenguer. Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: Experience of a transplant center in the Mediterranean basin. Gastroenterología y Hepatología (English Edition) 2022;45:177
    https://doi.org/10.1016/j.gastre.2021.03.014
  37. Natália de Carvalho Trevizoli, Evelyn Jacome Obeid, Silas Gustavo Barboza Romeres, Carolina Augusta Matos de Oliveira, Henrique Carvalho Rocha, Daniela Mariano Carvalho-Louro, Gustavo de Sousa Arantes Ferreira, Priscila Brizolla De Campos, Raquel Francine Bundchen Ullmann, Ana Virgínia Ferreira Figueira, Luiz Gustavo Guedes Diaz, Fernando Marcus Felippe Jorge, Gabriel Oliveira Nunes Caja, Zuleica Barrio Bortoli, André Luis Conde Watanabe. Liver Transplant and Active Ulcerative Colitis: A Case Report. Transplantation Proceedings 2022;54:1361
    https://doi.org/10.1016/j.transproceed.2022.03.041
  38. Charlotte Rose Hawkey Hedin, Gina Sado, Nelson Ndegwa, Ellina Lytvyak, Andrew Mason, Aldo Montano-Loza, Alessio Gerussi, Francesca Saffioti, Douglas Thorburn, Emma Nilsson, Geir Larsson, Bjørn A. Moum, Kim N. van Munster, Cyriel Y. Ponsioen, Cynthia Levy, Nicholas F. Nogueira, Christopher L. Bowlus, Neta Gotlieb, Oren Shibolet, Kate D. Lynch, Roger W. Chapman, Christian Rupp, Mette Vesterhus, Kristin K. Jørgensen, Fredrik Rorsman, Christoph Schramm, João Sabino, Severine Vermeire, Alessandra Zago, Nora Cazzagon, Hanns-Ulrich Marschall, Henriette Ytting, Karima Ben Belkacem, Olivier Chazouilleres, Sven Almer, Annika Bergquist. Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology 2020;18:2295
    https://doi.org/10.1016/j.cgh.2020.02.014
  39. Pavel Wohl, Alzbeta Krausova, Petr Wohl, Ondrej Fabian, Lukas Bajer, Jan Brezina, Pavel Drastich, Mojmir Hlavaty, Petra Novotna, Michal Kahle, Julius Spicak, Martin Gregor. Limited validity of Mayo endoscopic subscore in ulcerative colitis with concomitant primary sclerosing cholangitis. World J Gastrointest Endosc 2024;16:607
    https://doi.org/10.4253/wjge.v16.i11.607
  40. Carlo Selmi, Elena Generali, Merrill Eric Gershwin. Rheumatic Manifestations in Autoimmune Liver Disease. Rheumatic Disease Clinics of North America 2018;44:65
    https://doi.org/10.1016/j.rdc.2017.09.008
  41. Henrique C. Rocha, Eduardo G. Vilela. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases. Gastroenterología y Hepatología (English Edition) 2022;45:83
    https://doi.org/10.1016/j.gastre.2021.03.011
  42. Cristian Camilo Villa-Gómez, Daniel Stiven Velilla-Aguirre, Laura Camila Lopera-Restrepo, Sergio Iván Hoyos-Duque. Colangitis esclerosante primaria. Una revisión narrativa. Iatreia 2020;33:251
    https://doi.org/10.17533/udea.iatreia.57
  43. Arshdeep Singh, Vandana Midha, Vikram Narang, Saurabh Kedia, Ramit Mahajan, Pavan Dhoble, Bhavjeet Kaur Kahlon, Ashvin Singh Dhaliwal, Ashish Tripathi, Shivam Kalra, Narender Pal Jain, Namita Bansal, Rupa Banerjee, Devendra Desai, Usha Dutta, Vineet Ahuja, Ajit Sood. Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India. Intest Res 2023;21:452
    https://doi.org/10.5217/ir.2022.00087
  44. Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. WJH 2021;13:1828
    https://doi.org/10.4254/wjh.v13.i12.1828
  45. Katy L. Lawson, Hanlin L. Wang. Primary Sclerosing Cholangitis, Small Duct Primary Sclerosing Cholangitis, IgG4-Related Sclerosing Cholangitis, and Ischemic Cholangiopathy. Surgical Pathology Clinics 2023;16:533
    https://doi.org/10.1016/j.path.2023.04.008
  46. Yong Eun Park, Jae Hee Cheon, Jae Jun Park, Yoon Jae Kim, Chang Hwan Choi, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim. Risk factors and clinical courses of concomitant primary sclerosing cholangitis and ulcerative colitis: a Korean multicenter study. Int J Colorectal Dis 2018;33:1497
    https://doi.org/10.1007/s00384-018-3123-6
  47. Raouf Nassar, Orith Waisbourd‐Zinman. Autoimmune liver disease in gastrointestinal conditions. Clinical Liver Disease 2022;20:108
    https://doi.org/10.1002/cld.1223
  48. Tina Boortalary, David Loren. Hepato-Pancreato-Biliary Malignancies. 2022.
    https://doi.org/10.1007/978-3-030-37482-2_15-1
  49. Martin Cornillet, Christina Villard, Fredrik Rorsman, Antonio Molinaro, Emma Nilsson, Stergios Kechagias, Erik von Seth, Annika Bergquist. The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM). eClinicalMedicine 2024;70:102526
    https://doi.org/10.1016/j.eclinm.2024.102526
  50. You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis. Exp Mol Med 2023;55:1380
    https://doi.org/10.1038/s12276-023-01042-9
  51. Ali Reza Safarpour, Sara Shojaei-Zarghani, Manoosh Mehrabi, Abbas Ali Keshtkar, Ali Akbar Oroojan, Gholam Reza Sivandzadeh. Alterations in the Course of Inflammatory Bowel Disease Following Liver Transplantation: A Systematic Review and Meta-analysis. 2023;29:973
    https://doi.org/10.1093/ibd/izac132
  52. Abdullah Alotaibi, Abrar Alhubayshi, Abed Allehibi, Abdullah Almtawa, Nawaf Alotaibi, Adel Alghamdi, Saad Alrajhi, Adel Alqutub, Ahmad Aleid, Abdulrhman Alamr, Bashaar Ibrahim, Mohammed Alahmari, Hussam Alhamidi, Shameem Ahmad, Hadeel AlBayyat, Osama Alshaya, Youssef Altannir, Ahmed Alghamdi. Prevalence of Classical Extraintestinal Manifestations among Inflammatory Bowel Disease Patients in Saudi Arabia: A Single Tertiary Center Experience. 2024;12:169
    https://doi.org/10.4103/sjmms.sjmms_139_23
  53. Robert van Vorstenbosch, Kim van Munster, Georgios Stavropoulos, Daniëlle Pachen, Frederik-Jan van Schooten, Cyriel Ponsioen, Agnieszka Smolinska. The potential of volatile organic compounds to diagnose primary sclerosing cholangitis. JHEP Reports 2024;6:101103
    https://doi.org/10.1016/j.jhepr.2024.101103
  54. Atsushi Tanaka. IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis. Gut and Liver 2019;13:300
    https://doi.org/10.5009/gnl18085
  55. Theodore J. Wigle, Elena V. Tsvetkova, Stephen A. Welch, Richard B. Kim. DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report. Pharmaceutics 2019;11:199
    https://doi.org/10.3390/pharmaceutics11050199
  56. Hannah W. Fiske, Firrah Saeed, Christopher Ward, Boris Sinayuk, Veronica Ulici, Michael Curry, Edward Feller, Samir A. Shah. Coexisting Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Overlapping Challenges in Diagnosis and Treatment. Case Rep Gastroenterol 2024;18:167
    https://doi.org/10.1159/000537798
  57. Rui Gaspar, Catarina Castelo Branco, Guilherme Macedo. Liver manifestations and complications in inflammatory bowel disease: A review. WJH 2021;13:1956
    https://doi.org/10.4254/wjh.v13.i12.1956
  58. Gres Karim, Dewan Giri, Tatyana Kushner, Nancy Reau. Evaluation of Liver Disease in Pregnancy. Clinics in Liver Disease 2023;27:133
    https://doi.org/10.1016/j.cld.2022.08.009
  59. Claire Kelly, Yoh Zen, Michael A. Heneghan. Post-Transplant Immunosuppression in Autoimmune Liver Disease. Journal of Clinical and Experimental Hepatology 2023;13:350
    https://doi.org/10.1016/j.jceh.2022.07.002
  60. Rodrigo V Motta, Vipin Gupta, Karen Hartery, Paul Bassett, Simon J Leedham, Roger W Chapman, Simon PL Travis, Emma L Culver, James E. East. Dye-based chromoendoscopy detects more neoplasia than white light endoscopy in patients with primary sclerosing cholangitis and IBD. Endosc Int Open 2024;12:E1285
    https://doi.org/10.1055/a-2437-8102
  61. Zahra Alipour, Kristen Stashek. Recently described types of dysplasia associated with IBD: tips and clues for the practising pathologist. J Clin Pathol 2024;77:77
    https://doi.org/10.1136/jcp-2023-209141
  62. Junmin Song, Yang Li, Christopher L. Bowlus, GuoXiang Yang, Patrick S. C. Leung, M. Eric Gershwin. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review. Clinic Rev Allerg Immunol 2020;58:134
    https://doi.org/10.1007/s12016-019-08764-7
  63. Vilja Koskensalo, Andrea Tenca, Marianne Udd, Outi Lindström, Mia Rainio, Kalle Jokelainen, Leena Kylänpää, Martti Färkkilä. Diclofenac does not reduce the risk of acute pancreatitis in patients with primary sclerosing cholangitis after endoscopic retrograde cholangiography. UEG Journal 2020;8:462
    https://doi.org/10.1177/2050640620912608
  64. G. R. Bikbavova, V. A. Livzan, V. A. Akhmedov, T. V. Tretyakova, V. A. Voyat, L. I. Telyatnikova. A clinical case of a continuous course of ulcerative with extra-intestinal manifestations. Medicinskij alfavit 2024:13
    https://doi.org/10.33667/2078-5631-2024-5-13-17
  65. A. V. Nikitin, G. V. Volynets. Sclerosing cholangitis and inflammatory bowel disease: which comes first?. Ross. vestn. perinatol. pediatr. 2021;66:39
    https://doi.org/10.21508/1027-4065-2021-66-1-39-46
  66. Hon Yan Ng, Orlee R. Guttman, Lori B. Tucker. Chronic recurrent multifocal osteomyelitis and primary sclerosing cholangitis with type 1 autoimmune hepatitis in a child with ulcerative colitis: a case report. BMC Rheumatol 2021;5
    https://doi.org/10.1186/s41927-021-00186-3
  67. You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko. Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease. Intest Res 2023;21:420
    https://doi.org/10.5217/ir.2023.00039
  68. Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Primary sclerosing cholangitis and inflammatory bowel disease: Intestine–liver interrelation. Gastroenterología y Hepatología (English Edition) 2019;42:316
    https://doi.org/10.1016/j.gastre.2019.02.030
  69. Burak Demir, Elgin Özkan, Seda Kaynak Şahap, Gizem Sütçü, Ceyda Tuna Kırsaçlıoğlu, Çiğdem Soydal, Ömer Suat Fitoz, Aydan Kansu Tanca, Emel Ünal. A Rare Case of “Periportal Cuffing” as an Incidental Finding on 18F-FDG PET/CT. Mirt 2023;32:252
    https://doi.org/10.4274/mirt.galenos.2023.53254
  70. Kevin P. Quinn, Siri A. Urquhart, Laurens P. Janssens, Ryan J. Lennon, Victor G. Chedid, Laura E. Raffals. Primary Sclerosing Cholangitis–Associated Pouchitis: A Distinct Clinical Phenotype. Clinical Gastroenterology and Hepatology 2022;20:e964
    https://doi.org/10.1016/j.cgh.2021.02.006
  71. Parita Patel, Sushila Dalal. Hepatic Manifestations of Inflammatory Bowel Disease. Clinical Liver Disease 2021;17:292
    https://doi.org/10.1002/cld.1046
  72. E. A. Yablokova, A. K. Dzhabarova, M. M. Lokhmatov, A. V. Gorelov, S. B. Krutikhina, M. I. Erokhina, E. V. Chibrina, A. M. Rimskaya, A. I. Khavkin. Extraintestinal manifestations in infl ammatory bowel diseases in children, a modern view of the problem. jour 2023;1:165
    https://doi.org/10.31146/1682-8658-ecg-209-1-165-177
  73. Rafael García Duperly, Rocío del Pilar López Panqueva, Eduardo Emilio Londoño Schimmer, Adriana Margarita María Rey Rubiano, Jorge Padron Mercado, Anwar Yair Medellín Abueta, Marcela Mejía Arango, Diego Andrés Aguirre Matallana, Mónica Juliana Ortíz Pereira, Cristian Camilo Páez Cancelado, Jong Hyuk Park Noh, Roberto Javier Vallejo Madroñero, Andrés José Gómez Aldana, Belén Elvira Mendoza de Molano. Características de la enfermedad inflamatoria intestinal con respecto a otros centros nacionales de Colombia. Rev. colomb. Gastroenterol. 2022;37:48
    https://doi.org/10.22516/25007440.752
  74. Burcin Özdirik, Tobias Müller, Alexander Wree, Frank Tacke, Michael Sigal. The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies. IJMS 2021;22:6975
    https://doi.org/10.3390/ijms22136975
  75. Tej I Mehta, Simcha Weissman, Brian M Fung, James H Tabibian. Geoepidemiologic variation in outcomes of primary sclerosing cholangitis. WJH 2020;12:116
    https://doi.org/10.4254/wjh.v12.i4.116
  76. Dania Hudhud, Angela Wu, Raymond K. Cross. Current Screening and Management Strategies for Dysplasia in IBD. Curr Treat Options Gastro 2023;21:218
    https://doi.org/10.1007/s11938-023-00412-6
  77. Omar K. Jamil, Dustin Shaw, Zifeng Deng, Nicholas Dinardi, Natalie Fillman, Shivani Khanna, Noa Krugliak Cleveland, Atsushi Sakuraba, Christopher R. Weber, Russell D. Cohen, Sushila Dalal, Bana Jabri, David T. Rubin, Joel Pekow. Inflammation in the proximal colon is a risk factor for the development of colorectal neoplasia in inflammatory bowel disease patients with primary sclerosing cholangitis. Therap Adv Gastroenterol 2023;16
    https://doi.org/10.1177/17562848231184985
  78. Igor V. Maev, Igor G. Bakulin, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva. Inflammatory bowel diseases: Transformation of representations. A review. Terapevticheskii arkhiv 2023;95:1064
    https://doi.org/10.26442/00403660.2023.12.202507
  79. Zhen-Jiao Li, Hong-Zhong Gou, Yu-Lin Zhang, Xiao-Jing Song, Lei Zhang. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value. World J Gastroenterol 2022;28:6213
    https://doi.org/10.3748/wjg.v28.i44.6213
  80. P. Thomson, P. Núñez, R. Quera, C. Bay. Gastrointestinal microbiome, what is behind faecal microbiota transplantation?. New Microbes and New Infections 2021;42:100898
    https://doi.org/10.1016/j.nmni.2021.100898
  81. Rebecca Little, Eytan Wine, Binita M Kamath, Anne M Griffiths, Amanda Ricciuto. Gut microbiome in primary sclerosing cholangitis: A review. WJG 2020;26:2768
    https://doi.org/10.3748/wjg.v26.i21.2768
  82. Lijun Liao, Kai Markus Schneider, Eric J C Galvez, Mick Frissen, Hanns-Ulrich Marschall, Huan Su, Maximilian Hatting, Annika Wahlström, Johannes Haybaeck, Philip Puchas, Antje Mohs, Jin Peng, Ina Bergheim, Anika Nier, Julia Hennings, Johanna Reißing, Henning W Zimmermann, Thomas Longerich, Till Strowig, Christian Liedtke, Francisco J Cubero, Christian Trautwein. Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis. Gut 2019;68:1477
    https://doi.org/10.1136/gutjnl-2018-316670
  83. Robert M. Marks, Kathryn J. Fowler, Mustafa R. Bashir. MR Imaging of Diffuse Liver Disease. Magnetic Resonance Imaging Clinics of North America 2021;29:347
    https://doi.org/10.1016/j.mric.2021.05.004
  84. Macarena Klein, Paulina Núñez, Constanza Bay, Carolina Pizarro, Rocío Sedano, Rodrigo Quera. Liver Disorders in Inflammatory Bowel Disease. EMJ Hepatol 2020:26
    https://doi.org/10.33590/emjhepatol/20-00040
  85. Keisaku Sato, Fanyin Meng, Giammarco Fava, Shannon Glaser, Gianfranco Alpini. Functional roles of gut bacteria imbalance in cholangiopathies. Liver Research 2019;3:40
    https://doi.org/10.1016/j.livres.2018.11.001
  86. Herbert Tilg, Timon E. Adolph, Michael Trauner. Gut-liver axis: Pathophysiological concepts and clinical implications. Cell Metabolism 2022;34:1700
    https://doi.org/10.1016/j.cmet.2022.09.017
  87. Christina Villard, Carl Jorns, Annika Bergquist. Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: a comprehensive review. egastro 2024;2:e100045
    https://doi.org/10.1136/egastro-2023-100045
  88. Giulia Catassi, Giulia D’Arcangelo, Lorenzo Norsa, Matteo Bramuzzo, Iva Hojsak, Kaija-Leena Kolho, Claudio Romano, Marco Gasparetto, Angelo Di Giorgio, Seamus Hussey, Anat Yerushalmy-Feler, Dan Turner, Manar Matar, Batia Weiss, Anna Karoliny, Patrizia Alvisi, Christos Tzivinikos, Marina Aloi. Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN. 2024;30:1662
    https://doi.org/10.1093/ibd/izad218
  89. Sabina Wiecek, Alicja Wojtyniak, Barbara Pindur, Magdalena Machnikowska-Sokołowska, Katarzyna Gruszczyńska, Urszula Grzybowska-Chlebowczyk. Analysis of the Clinical Course of Primary Sclerosing Cholangitis in Paediatric Population—Single Center Study. Medicina 2021;57:663
    https://doi.org/10.3390/medicina57070663
  90. Farhad Peerani, Lillian Du, Ellina Lytvyak, Vincent G Bain, Andrew L Mason, Robert J Bailey, Aldo J Montano-Loza. Serum IgG4 cut-off of 70 mg/dL is associated with a shorter time to cirrhosis decompensation and liver transplantation in primary sclerosing cholangitis patients. CanLivJ 2022;5:31
    https://doi.org/10.3138/canlivj-2021-0023
  91. Shintaro Akiyama, Soma Fukuda, Joshua M Steinberg, Hideo Suzuki, Kiichiro Tsuchiya. Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases. WJG 2022;28:2843
    https://doi.org/10.3748/wjg.v28.i25.2843
  92. Olga V. Usoltseva, Andrey N. Surkov, Alexander S. Potapov, Goar B. Movsisyan, Vladislav V. Chernikov. Association of autoimmune hepatobiliary pathology with inflammatory bowel diseases in children. RPJ 2022;25:106
    https://doi.org/10.46563/1560-9561-2022-25-2-106-115
  93. Corina Meianu, Tudor Stroie, Doina Istratescu, Carmen Monica Preda, Mihai Mircea Diculescu. Diagnosis and Medical Treatment of Acute and Chronic Idiopathic Pouchitis in Inflammatory Bowel Disease. Medicina 2024;60:979
    https://doi.org/10.3390/medicina60060979
  94. Mohamed Attauabi, Mirabella Zhao, Flemming Bendtsen, Johan Burisch. Systematic review and meta-analysis: the impact of co-occurring immune-mediated inflammatory diseases on the disease localization and behavior of Crohn’s disease. Therap Adv Gastroenterol 2021;14
    https://doi.org/10.1177/17562848211004839
  95. Sofía Frigerio, Dalia A. Lartey, Geert R. D’Haens, Joep Grootjans. The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms. IJMS 2021;22:12739
    https://doi.org/10.3390/ijms222312739
  96. Hao Zhang, Huiru Xin, Mengqi Zhao, Chenyang Bi, Yafei Xiao, Yifan Li, Changjiang Qin. Global research trends on the relationship between IBD and CRC: a bibliometric analysis from 2000 to 2023. J Health Popul Nutr 2024;43
    https://doi.org/10.1186/s41043-024-00577-5
  97. Nathália Fernanda Gouveia Madureira Teodoro, Bianca Gonçalves Rodrigues, Guilherme Victor Castro De Paulo, Lusmaio Batista De Sousa Júnior, Danúbio Antônio De Oliveira. Colangite esclerosante primária associada às doenças inflamatórias intestinais. Cuad. Ed. Desar. 2024;16
    https://doi.org/10.55905/cuadv16n2-ed.esp.239
  98. Elena Marcus, Paddy Stone, Anna-Maria Krooupa, Douglas Thorburn, Bella Vivat. Quality of life in primary sclerosing cholangitis: a systematic review. Health Qual Life Outcomes 2021;19
    https://doi.org/10.1186/s12955-021-01739-3
  99. Abdolmehdi Baghaei, MohammadHassan Emami, Peyman Adibi, Hamid Tavakkoli, Hamed Daghaghzadeh, Babak Tamizifar, MohammadJavad Akbarpour, Badri Hojjatpour. Inflammatory bowel disease registry and monitoring: Feasibility study and application (Isfahan Inflammatory Bowel Disease Surveillance Project). Int J Prev Med 2019;10:190
    https://doi.org/10.4103/ijpvm.IJPVM_316_17
  100. Chuan Liu, Rong Yu, Jixiang Zhang, Shuchun Wei, Fumin Xue, Yingyun Guo, Pengzhan He, Lining Shang, Weiguo Dong. Research hotspot and trend analysis in the diagnosis of inflammatory bowel disease: A machine learning bibliometric analysis from 2012 to 2021. Front. Immunol. 2022;13
    https://doi.org/10.3389/fimmu.2022.972079
  101. Sara Jarmakiewicz-Czaja, Jolanta Gruszecka, Rafał Filip. What Do NAFLD, Liver Fibrosis, and Inflammatory Bowel Disease Have in Common? Review of the Current Literature. Metabolites 2023;13:378
    https://doi.org/10.3390/metabo13030378
  102. Bence Kővári, Rish K. Pai. Upper Gastrointestinal Tract Involvement in Inflammatory Bowel Diseases: Histologic Clues and Pitfalls. 2022;29:2
    https://doi.org/10.1097/PAP.0000000000000311
  103. Lukáš Bajer, Pavel Wohl, Pavel Drastich. PSC-IBD: specific phenotype of inflammatory bowel disease associated with primary sclerosing cholangitis. Vnitř Lék 2018;64:659
    https://doi.org/10.36290/vnl.2018.090
  104. Ahmad Hassan Ali, Elizabeth J. Carey. Diagnosis and Management of Cholangiocarcinoma. 2018.
    https://doi.org/10.1007/978-3-030-70936-5_20
  105. Annarosa Floreani, Sara De Martin, Maria Francesca Secchi, Nora Cazzagon. Extrahepatic autoimmunity in autoimmune liver disease. European Journal of Internal Medicine 2019;59:1
    https://doi.org/10.1016/j.ejim.2018.10.014
  106. Yihong R. Ma, Alexandros D. Polydorides. Clinicopathologic Characteristics and Neoplasia Risk of Colorectal Inflammatory Polyposis in Inflammatory Bowel Disease. 2022;146:172
    https://doi.org/10.5858/arpa.2020-0745-OA
  107. Alejandro Mínguez, Isabel Conde, Cristina Montón, Lara Gonzalez, Sonia Pascual, María Dolores Antón, Antonio Palau, Ana Forés, Concha Gisbert, Asunción Ojeda, Eva Girona, Tommaso Di Maira, Marina Berenguer. Primary Sclerosing Cholangitis: Gender Effects in Valencia’s Low-Prevalence Region. Dig Dis Sci 2024;69:1863
    https://doi.org/10.1007/s10620-024-08368-y
  108. Amanda Ricciuto, Binita M. Kamath, Anne M. Griffiths. The IBD and PSC Phenotypes of PSC-IBD. Curr Gastroenterol Rep 2018;20
    https://doi.org/10.1007/s11894-018-0620-2
  109. Chiraag Kulkarni, Soumya Murag, George Cholankeril, Touran Fardeen, Ajitha Mannalithara, Robert Lerrigo, Ahmad Kamal, Aijaz Ahmed, Aparna Goel, Sidhartha R Sinha. Association of Anti-TNF Therapy With Increased Risk of Acute Cholangitis in Patients With Primary Sclerosing Cholangitis. 2021;27:1602
    https://doi.org/10.1093/ibd/izaa317
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd